Crossmark

Ten years of Genome Medicine

Crossref DOI link: https://doi.org/10.1186/s13073-019-0618-x

Published Online: 2019-02-15

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Auffray, Charles

Griffin, Julian L.

Khoury, Muin J.

Lupski, James R.

Schwab, Matthias
License Information

Text and Data Mining valid from 2019-02-15
More Information

Article History

First Online: 15 February 2019

Competing interests

: Baylor College of Medicine (BCM) and Miraca Holdings have formed a joint venture with shared ownership and governance of the Baylor Genetics (BG). The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from chromosomal microarray analysis and clinical exome sequencing offered by the Baylor Genetics (BG) Laboratory (ExternalRef removed). JRL is a member of the Scientific Advisory Board of BG. JRL has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, and is a co-inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. The remaining authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.